Approvals/TGA/SITAGLIPTIN LAPL sitagliptin (as hydrochloride monohydrate) 50 mg tablet blister pack

Approved

STANDARD

SITAGLIPTIN LAPL sitagliptin (as hydrochloride monohydrate) 50 mg tablet blister pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: d4059b4fdd67623a
Product Name: SITAGLIPTIN LAPL sitagliptin (as hydrochloride monohydrate) 50 mg tablet blister pack
Artg Id: 297344
Artg Name: SITAGLIPTIN LAPL sitagliptin (as hydrochloride monohydrate) 50 mg tablet blister pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2020-05-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d4059b4fdd67623a

Type

Standard